← Back to Search

Other

Hyperbaric oxygen therapy-TBI for Post-Traumatic Brain Injury Syndrome

Phase 1
Waitlist Available
Led By Paul G Harch, M.D.
Research Sponsored by Paul G. Harch, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Adults or children with traumatic brain injury at least one year old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after the final hbot
Awards & highlights
No Placebo-Only Group

Summary

Hypothesis: That SPECT brain imaging tracks and is consistent with clinical improvements in patients receiving hyperbaric oxygen therapy (HBOT) for chronic traumatic brain injury.

Eligible Conditions
  • Post-Traumatic Brain Injury Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after completion of hbot
This trial's timeline: 3 weeks for screening, Varies for treatment, and after completion of hbot for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
SPECT brain imaging
Secondary study objectives
Cognitive testing

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hyperbaric oxygen therapy-TBIExperimental Treatment1 Intervention
Low pressure hyperbaric oxygen therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric oxygen therapy
2013
Completed Phase 3
~1500

Find a Location

Who is running the clinical trial?

Harch Hyperbaric Research FoundationOTHER
3 Previous Clinical Trials
130 Total Patients Enrolled
Paul G. Harch, M.D.Lead Sponsor
4 Previous Clinical Trials
160 Total Patients Enrolled
Paul G Harch, M.D.Principal InvestigatorLSU School of Medicine, New Orleans
4 Previous Clinical Trials
160 Total Patients Enrolled
~2 spots leftby Nov 2025